|
WO2016074033A1
|
|
Tumour necrosis factor (tnf)-related apoptosis-inducing ligand (trail): compositions and methods for treating wound healing
|
|
US2015191446A1
|
|
Seleno-compounds and therapeutic uses thereof
|
|
WO2011047412A1
|
|
Tyrosine and l-dopa for reducing l-dopa incorporation into proteins
|
|
EP2304049A1
|
|
Method of treatment of vascular complications
|
|
EP2307026A1
|
|
The use of androgens for vascular regeneration and endothelial repair
|
|
AU2330302A
|
|
Cyclodextrins and reversal of atherosclerosis
|
|
WO0204031A1
|
|
Compositions and methods for treating cardiovascular disorders
|
|
AU7219101A
|
|
Compositions and methods for treating cardiovascular disorders
|
|
CA2392355A1
|
|
Oxidized apolipoproteins and methods of use
|
|
AU1681801A
|
|
Oxidized apolipoproteins and methods of use
|
|
CA2251269A1
|
|
A method for detection of potential co-antioxidants
|
|
EP0550506A1
|
|
Novel chemotactic factor
|
